- Home
- GTY vs VCEL Comparison
GTY vs VCEL Comparison
Compare GTY & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTY | VCEL |
|---|---|---|
| Founded | 1955 | 1989 |
| Country | United States | United States |
| Employees | 31 | 398 |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 1998 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GTY | VCEL |
|---|---|---|
| Price | $32.88 | $34.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $32.60 | ★ $57.75 |
| AVG Volume (30 Days) | 327.6K | ★ 592.4K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.92% | N/A |
| EPS Growth | 8.00 | ★ 60.00 |
| EPS | ★ 0.43 | N/A |
| Revenue | $221,727,000.00 | ★ $276,259,000.00 |
| Revenue This Year | $9.39 | $19.40 |
| Revenue Next Year | $7.83 | $18.24 |
| P/E Ratio | $76.05 | ★ N/A |
| Revenue Growth | 9.02 | ★ 16.45 |
| 52 Week Low | $25.39 | $28.95 |
| 52 Week High | $34.75 | $45.97 |
Technical Indicators
Market Signals| Indicator | GTY | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 52.82 |
| Support Level | $32.56 | $34.30 |
| Resistance Level | $34.08 | $38.31 |
| Average True Range (ATR) | 0.48 | 2.04 |
| MACD | -0.06 | -0.21 |
| Stochastic Oscillator | 51.75 | 33.70 |
Price Performance
Historical ComparisonAbout GTY Getty Realty Corporation
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.